Clinical Trial Update: A New Anthrax Vaccine Administered by the Intramuscular (IM) Route in Healthy Adults [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated a new intramuscular anthrax vaccine in healthy adults and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anthrax

Drugs mentioned

• Anthrax vaccine (intramuscular) (anthrax vaccine)

Snippet

Sponsor: DynPort Vaccine Company LLC, A GDIT Company | Conditions: Anthrax | Phase 1 | Status: COMPLETED